Boc-3-Hydroxy-1-Adamantyl-D-Glycine CAS 361442-00-4 Mimọ>99.5% EE>99.5%

Apejuwe kukuru:

Orukọ: Boc-3-Hydroxy-1-Adamantyl-D-Glycine

CAS: 361442-00-4

Mimo:>99.5% (GC) EE:>99.5%

Irisi: Funfun tabi Paa-White Crystalline Powder

Agbedemeji API (CAS: 361442-04-8)

E-Mail: alvin@ruifuchem.com


Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Kemikali Properties:

Orukọ Kemikali Boc-3-Hydroxy-1-Adamantyl-D-Glycine
Awọn itumọ ọrọ sisọ (2S)-2-((tert-Butoxycarbonyl)amino)-2-(3-Hydroxyadamantan-1-yl) acetic Acid
Nọmba CAS 361442-00-4
NỌMBA CAT RF-PI1989
Iṣura Ipo Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Ilana molikula C17H27NO5
Òṣuwọn Molikula 325.40
Ojuami farabale 497,3 ± 20,0 ℃
iwuwo 1.296
Brand Ruifu Kemikali

Awọn pato:

Nkan Awọn pato
Ifarahan Funfun tabi Pa-White Crystalline Powder
Omi (KF) <0.50%
Pipadanu lori Gbigbe <1.00%
Aloku lori Iginisonu <0.50%
Aimọ Kanṣoṣo <0.50%
Lapapọ Awọn Aimọ <0.50%
EE > 99.5%
Mimo > 99.5%
Infurarẹẹdi julọ.Oniranran Ni ibamu si Eto
Igbeyewo Standard Standard Enterprise
Lilo elegbogi Intermediates

Package & Ibi ipamọ:

Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin

Awọn anfani:

1

FAQ:

Ohun elo:

Boc-3-Hydroxy-1-Adamantyl-D-Glycine (CAS: 361442-00-4) jẹ agbedemeji API (CAS: 361442-04-8).API (CAS: 361442-04-8)jẹ oludaniloju iyipada ti o lagbara ati yiyan ti dipeptidyl peptidase-4, eyiti o jẹ idagbasoke fun itọju iru àtọgbẹ 2.O gba ni iyara lẹhin iṣakoso ẹnu ati pe o ni profaili elegbogi ti o ni ibamu pẹlu iwọn lilo lẹẹkan lojoojumọ.O jẹ dipeptidyl peptidase-4 (DPP-4) inhibitor antidiabetic fun itọju iru àtọgbẹ 2.Awọn inhibitors DPP-4 jẹ kilasi ti awọn agbo ogun ti o ṣiṣẹ nipa ni ipa iṣe ti awọn homonu adayeba ninu ara ti a pe ni incretins.OA lo pẹlu ounjẹ ati adaṣe lati mu iṣakoso suga ẹjẹ pọ si ni awọn agbalagba ti o ni àtọgbẹ iru 2.Kii ṣe fun itọju iru àtọgbẹ 1.ONigba miiran a lo ni apapo pẹlu awọn oogun alakan miiran.O ti de nipasẹ ifowosowopo ti AstraZeneca ati Bristol-Myers Squibb Company ati pe o jẹ ti inhibitor DPP-IV.

Kọ ifiranṣẹ rẹ nibi ki o si fi si wa